Search Results - "Unglaub, Petra"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Detection of a Pseudonormal Mitral Inflow Pattern: An Echocardiographic and Tissue Doppler Study by Poerner, Tudor C., Goebel, Björn, Unglaub, Petra, Sueselbeck, Tim, Strotmann, Jörg M., Pfleger, Stefan, Borggrefe, Martin, Haase, Karl K.

    Published in Echocardiography (Mount Kisco, N.Y.) (01-05-2003)
    “…Objective: The aim of this study was to assess the ability of several echocardiographic and tissue Doppler imaging (TDI) derived parameters to improve the…”
    Get full text
    Journal Article
  2. 2

    Immunotherapy in urologic oncology : Response and treatment interruptions due to adverse events in a bicentric real-world analysis by Burger, Ralph, Jarczyk, Jonas, Westhoff, Niklas, Worst, Thomas S, Herrmann, Jonas, Merx, Kirsten, Weidner, Anja, Unglaub, Petra, Müller, Markus, Nuhn, Philipp, Michel, Maurice Stephan, von Hardenberg, Jost

    Published in Urologe. Ausgabe A (01-07-2022)
    “…Immune checkpoint inhibitors (ICI) have been approved in uro-oncology for a few years. Real-world experience regarding benefits and risks with novel side…”
    Get full text
    Journal Article
  3. 3

    Non-invasive evaluation of left ventricular filling pressures in patients with abnormal relaxation by Poerner, Tudor C, Goebel, Björn, Unglaub, Petra, Süselbeck, Tim, Kaden, Jens J, Borggrefe, Martin, Haase, Karl K

    Published in Clinical science (1979) (01-05-2004)
    “…The aim of the present study was to assess the ability of several echocardiographic and TDI (tissue Doppler imaging) parameters to predict an elevated LVEDP…”
    Get more information
    Journal Article
  4. 4

    Immuntherapien in der Uroonkologie by Burger, Ralph, Jarczyk, Jonas, Westhoff, Niklas, Worst, Thomas S, Herrmann, Jonas, Merx, Kirsten, Weidner, Anja, Unglaub, Petra, Müller, Markus, Nuhn, Philipp, Michel, Maurice Stephan, von Hardenberg, Jost

    Published in Urologe. Ausgabe A (01-07-2022)
    “…ZusammenfassungHintergrundImmun-Checkpoint-Inhibitoren (ICI) sind seit wenigen Jahren in der Uroonkologie zugelassen. Real-world-Erfahrung zu Nutzen und…”
    Get full text
    Journal Article